TWST
HEALTHCARETwist Bioscience Corp
$59.53+2.83 (+4.99%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving TWST Today?
No stock-specific AI insight has been generated for TWST yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$23.30$66.06
$59.53
Fundamentals
Market Cap$3.7B
P/E Ratio—
EPS$-1.32
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume1.4M
Avg Volume (10D)—
Shares Outstanding62.3M
TWST News
20 articles- LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discoveryYahoo Finance·May 8, 2026
- Twist Bioscience Corp (TWST) Climbed on Earnings BeatYahoo Finance·May 8, 2026
- Twist Bioscience Corp. (TWST) Rallied on Record-Breaking Quarterly ReportYahoo Finance·May 8, 2026
- Did Twist’s Upbeat Revenue Guidance and Complex Genes Launch Just Shift Twist Bioscience's (TWST) Investment Narrative?Yahoo Finance·May 8, 2026
- Benchling Launches One-Click Ordering for Biopharma R&D with Twist Bioscience, Adaptyv, and Ginkgo BioworksYahoo Finance·May 6, 2026
- Company News for May 5, 2026Yahoo Finance·May 5, 2026
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Yahoo Finance·May 5, 2026
- Twist Bioscience Corporation Q2 2026 Earnings Call SummaryMoby·May 4, 2026
- Twist Bioscience Q2 Earnings Call HighlightsMarketbeat·May 4, 2026
- Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue EstimatesYahoo Finance·May 4, 2026
- Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex SequencesYahoo Finance·May 4, 2026
- Twist Bioscience Announces Fiscal 2026 Second Quarter Financial ResultsYahoo Finance·May 4, 2026
- Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026Yahoo Finance·Apr 21, 2026
- Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 OptimismYahoo Finance·Feb 25, 2026
- Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery OpportunityYahoo Finance·Feb 25, 2026
- Twist Bioscience to Present at Upcoming Investor ConferencesYahoo Finance·Feb 18, 2026
- Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing AgreementYahoo Finance·Feb 17, 2026
- Biotech Beat Nvidia in 2025. Can It Do It Again?Motley Fool·Feb 11, 2026
- Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary EnzymesYahoo Finance·Feb 10, 2026
- Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor RatificationMarketbeat·Feb 9, 2026
All 20 articles loaded
Price Data
Open$57.06
Previous Close$56.70
Day High$60.58
Day Low$57.00
52 Week High$66.06
52 Week Low$23.30
52-Week Range
$23.30$66.06
$59.53
Fundamentals
Market Cap$3.7B
P/E Ratio—
EPS$-1.32
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume1.4M
Avg Volume (10D)—
Shares Outstanding62.3M
About Twist Bioscience Corp
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—